Ultrasound Characteristics of Calf Deep Vein Thrombosis and Residual Vein Obstruction After Low Molecular Weight Heparin Treatment.
OBJECTIVE
Calf deep vein thrombosis (CDVT) is frequently found in symptomatic outpatients, but CDVT ultrasound diagnostic criteria are still debated. It has been proposed that only clots with ≥5 mm maximum diameter can be considered as CDVT.


OBJECTIVE
To assess clot diameters and characteristics of CDVT, and to assess the recanalization rate of CDVT after anticoagulant treatment.


METHODS
In a prospective, multicenter cohort study symptomatic outpatients in whom CDVT was diagnosed by ultrasound were enrolled. Posterior tibial, fibular, medial and lateral gastrocnemius, and soleal veins were compressed transversally over their entire length. Clot diameter was measured during maximum compression and ultrasound was repeated after 6 weeks of low molecular weight heparin treatment.


RESULTS
In 172 patients (age 70 ± 1 y, male 32%) CDVT was detected in 132 (76.7%) muscle veins only, and in 24 (14%) axial veins only, while 16 (9.3%) patients had both muscular and axial CDVT. A total of 212 clots were found with a diameter of 5.8 ± 1.8 mm (IQR 4.5-6.8 mm) with the 10th percentile being ≥3.5 mm. A cut off value of ≥5 mm had a sensitivity of 0.76 (95% CI 0.69-0.82), whereas a value of ≥3.5 mm had a sensitivity of 0.94 (95% CI 0.89-0.97). Recanalization (i.e. residual vein obstruction ≤2 mm) was found in 51% of patients and the recanalization rate was not correlated with clot diameter at enrolment (rho -0.128 p = 0.93) or with type of CDVT (axial vs. muscular thrombosis). Patients with significantly reduced mobility had lower probability of CDVT recanalization.


CONCLUSIONS
A clot diameter ≥5 mm is found in only 76% of CDVT patients and a clot diameter ≥3.5 mm may be more appropriate as a threshold for CDVT. After 6 weeks of anticoagulant treatment, half of CDVT patients had recanalization and recanalization was not correlated with clot characteristics at enrolment, but with mobility of the patients.
Department of Angiology and Blood Coagulation, University Hospital S. Orsola-Malpighi, Bologna, Italy. Electronic address: michelangelo.sartori@aosp.bo.it.
M
M
Sartori
Angiology Unit, Medicine and Geriatric Department, "Villa Serena" Hospital, Città Sant'Angelo, Pescara, Italy.
G
G
Lessiani
Department of Angiology and Blood Coagulation, University Hospital S. Orsola-Malpighi, Bologna, Italy.
E
E
Favaretto
Department of Angiology and Blood Coagulation, University Hospital S. Orsola-Malpighi, Bologna, Italy.
L
L
Migliaccio
Angiology Unit, Arcispedale S. Maria Nuova, Reggio Emilia, Italy.
M
M
Iotti
Non-invasive Vascular Diagnostic Unit, University Hospital S. Anna, Ferrara, Italy.
L
L
Giusto
Angiology Unit, Arcispedale S. Maria Nuova, Reggio Emilia, Italy.
A
A
Ghirarduzzi
Cardiovascular Diseases, University of Bologna, Bologna, Italy.
G
G
Palareti
Department of Angiology and Blood Coagulation, University Hospital S. Orsola-Malpighi, Bologna, Italy.
B
B
Cosmi
D000368:Aged; D000369:Aged, 80 and over; D000553:Ambulatory Care; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D019540:Area Under Curve; D017984:Enoxaparin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007558:Italy; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D051346:Mobility Limitation; D011237:Predictive Value of Tests; D011446:Prospective Studies; D012372:ROC Curve; D012074:Remission Induction; D015203:Reproducibility of Results; D013997:Time Factors; D016896:Treatment Outcome; D018616:Ultrasonography, Doppler, Duplex; D020246:Venous Thrombosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology
D000925:Anticoagulants; D017984:Enoxaparin
Calf deep vein thrombosis; Clot diameter; Heparin; Isolated distal deep vein thrombosis; Residual venous obstruction; Whole leg ultrasound